Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer-Reference-Cited by-同舟云学术

Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer

Published:2022-09 Issue:1 Volume:114 Page:163-172
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Wang Charles X.,Elganainy Dalia,Zaid Mohamed M.,Butner Joseph D.,Agrawal Anshuman,Nizzero Sara,Minsky Bruce D.,Holliday Emma B.,Taniguchi Cullen M.,Smith Grace L.,Koong Albert C.,Herman Joseph M.,Das Prajnan,Maitra Anirban,Wang Huamin,Wolff Robert A.,Katz Matthew H.G.,Crane Christopher H.,Cristini Vittorio,Koay Eugene J.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference45 articles.

1. Cancer statistics, 2018;Siegel;Cancer J Clin,2018

2. Current and emerging radiotherapy strategies for pancreatic adenocarcinoma: Stereotactic, intensity modulated and particle radiotherapy;Ng;Ann Pancreat Cancer,2018

3. Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: The LAP07 randomized clinical trial;Hammel;JAMA,2016

4. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma;Provenzano;Cancer Cell,2012

5. Desmoplasia of pancreatic ductal adenocarcinoma;Pandol;Clin Gastroenterol Hepatol,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy;Radiation Oncology;2023-08-18